BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 21623236)

  • 1. Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the Lung.
    Tsuta K; Tanabe Y; Yoshida A; Takahashi F; Maeshima AM; Asamura H; Tsuda H
    J Thorac Oncol; 2011 Jul; 6(7):1190-9. PubMed ID: 21623236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.
    Kim MJ; Shin HC; Shin KC; Ro JY
    Ann Diagn Pathol; 2013 Feb; 17(1):85-90. PubMed ID: 23040737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of clinical characteristics and differential diagnosis of the lung biopsy specimens in 99 adenocarcinoma cases and 111 squamous cell carcinoma cases: utility of an immunohistochemical panel containing CK5/6, CK34βE12, p63, CK7 and TTF-1.
    Xu XY; Yang GY; Yang JH; Li J
    Pathol Res Pract; 2014 Oct; 210(10):680-5. PubMed ID: 25063315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.
    Nicholson AG; Gonzalez D; Shah P; Pynegar MJ; Deshmukh M; Rice A; Popat S
    J Thorac Oncol; 2010 Apr; 5(4):436-41. PubMed ID: 20068475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of TTF-1, NapsinA, P63, CK5/6 in Lung Cancer and Its Diagnostic Values for Histological Classification].
    Yu H; Li L; Liu D; Li WM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 May; 48(3):336-341. PubMed ID: 28616902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of WT-1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions.
    Pu RT; Pang Y; Michael CW
    Diagn Cytopathol; 2008 Jan; 36(1):20-5. PubMed ID: 18064689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal combination of immunohistochemical markers for subclassification of non-small cell lung carcinomas: A tissue microarray study of poorly differentiated areas.
    Noh S; Shim H
    Lung Cancer; 2012 Apr; 76(1):51-5. PubMed ID: 21978426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens.
    Loo PS; Thomas SC; Nicolson MC; Fyfe MN; Kerr KM
    J Thorac Oncol; 2010 Apr; 5(4):442-7. PubMed ID: 20195168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples.
    Terry J; Leung S; Laskin J; Leslie KO; Gown AM; Ionescu DN
    Am J Surg Pathol; 2010 Dec; 34(12):1805-11. PubMed ID: 21107086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsies.
    Warth A; Muley T; Herpel E; Meister M; Herth FJ; Schirmacher P; Weichert W; Hoffmann H; Schnabel PA
    Histopathology; 2012 Dec; 61(6):1017-25. PubMed ID: 22882703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic value of TTF-1, CK 5/6, and p63 immunostaining in classification of lung carcinomas.
    Kargi A; Gurel D; Tuna B
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):415-20. PubMed ID: 18091384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung.
    Whithaus K; Fukuoka J; Prihoda TJ; Jagirdar J
    Arch Pathol Lab Med; 2012 Feb; 136(2):155-62. PubMed ID: 22288962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung.
    Argon A; Nart D; Veral A
    Turk Patoloji Derg; 2015; 31(2):81-8. PubMed ID: 25944390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of squamous cell carcinoma markers and adenocarcinoma markers in primary pulmonary neuroendocrine carcinomas.
    Masai K; Tsuta K; Kawago M; Tatsumori T; Kinno T; Taniyama T; Yoshida A; Asamura H; Tsuda H
    Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):292-7. PubMed ID: 23060301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
    Mukhopadhyay S; Katzenstein AL
    Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens.
    Rekhtman N; Ang DC; Sima CS; Travis WD; Moreira AL
    Mod Pathol; 2011 Oct; 24(10):1348-59. PubMed ID: 21623384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromogenic immunohistochemical quadruplex provides accurate diagnostic differentiation of non-small cell lung cancer.
    Roberts EA; Morrison LE; Behman LJ; Draganova-Tacheva R; O'Neill R; Solomides CC
    Ann Diagn Pathol; 2020 Apr; 45():151454. PubMed ID: 31923744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p40 is the best marker for diagnosing pulmonary squamous cell carcinoma: comparison with p63, cytokeratin 5/6, desmocollin-3, and sox2.
    Tatsumori T; Tsuta K; Masai K; Kinno T; Taniyama T; Yoshida A; Suzuki K; Tsuda H
    Appl Immunohistochem Mol Morphol; 2014; 22(5):377-82. PubMed ID: 24805133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Napsin-A and Desmocollin-3 in classifying poorly differentiating non-small cell lung carcinoma.
    Ezzat Nel-S; Tahoun N
    J Egypt Natl Canc Inst; 2016 Mar; 28(1):13-22. PubMed ID: 26710975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.
    Khayyata S; Yun S; Pasha T; Jian B; McGrath C; Yu G; Gupta P; Baloch Z
    Diagn Cytopathol; 2009 Mar; 37(3):178-83. PubMed ID: 19170169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.